Gabrielle Sulzberger - Jun 17, 2021 Form 4 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role
Director
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Stock symbol
CERE
Transactions as of
Jun 17, 2021
Transactions value $
$275,357
Form type
4
Date filed
6/22/2021, 06:31 PM
Previous filing
Jun 14, 2021
Next filing
Jun 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Purchase $275K +21.1K +147.75% $13.06 35.4K Jun 17, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.